Position in FTRE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,043,734
-$147,113 QoQ
Shares Held
117,456
-49.5% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#82
of 334 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Engineers Gate Manager LP holds $199,313,913 across 163 Biotechnology names. FTRE ranks #25 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
126,044 | $13,438,811 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
181,647 | $10,393,841 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,469 | $10,075,173 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,918 | $9,925,509 | |
| 5 | RPRX |
Royalty Pharma plc
|
137,994 | $7,737,323 | |
| 6 | EXEL |
Exelixis, Inc.
|
110,353 | $6,004,306 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
16,302 | $4,645,580 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
108,139 | $4,640,244 |
All Filings in FTRE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,043,734 | 117,456 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,190,847 | 232,574 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $644,460 | 37,360 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,069,516 | 127,021 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $875,797 | 177,287 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $711,617 | 94,254 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $1,209,992 | 51,842 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||